Mitomycin-C-Induced TTP/HUS Treated Successfully with Rituximab: Case Report and Review of the Literature
Microangiopathic hemolytic anemia (MAHA), thrombocytopenia, fever, renal failure, and neurologic symptoms comprise the cardinal features of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Etiologies can include medications, infections, cancers, or transplantation. We present a pat...
Main Authors: | Gunjan Shah, Hanah Yamin, Hedy Smith |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2013/130978 |
Similar Items
-
Juvenile Dermatomyositis (JDM) Complicated by Thrombotic Thrombocytopenic Purpura (TTP) and Purtscher's Retinopathy Responsive to Rituximab: Case Report and Literature Review
by: Keerthi Gullapalli, et al.
Published: (2020-08-01) -
Outcomes of Immune Thrombotic Thrombocytopenic Purpura (iTTP) With Upfront Cyclophosphamide vs. Rituximab
by: Mouhamed Yazan Abou-Ismail, et al.
Published: (2020-10-01) -
Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): a 24-year clinical experience with 178 patients
by: Lara Primo, et al.
Published: (2008-12-01) -
Bullous Pemphigoid Successfully Treated with Rituximab
by: Nuno Silva, et al.
Published: (2017-03-01) -
Refractory myasthenia gravis treated successfully with rituximab: A case report
by: L Yadav Rahul, et al.
Published: (2017-01-01)